During the last three months, 4 analysts shared their evaluations of Moderna (NASDAQ: MRNA ), revealing diverse outlooks from ...

Moderna Inc will soon apply for real-time reviews of its experimental COVID-19 vaccine in Europe, the drug developer said on Thursday, days after the EU health regulator launched rolling reviews of ...

The Moderna Innovation and Technology Centre in Harwell, Oxfordshire is now fully operational and Moderna is licensed to ...

Swiss contract drug manufacturer Lonza's plants in the United States and Switzerland are due to make ingredients for 400 million doses of Moderna's COVID-19 vaccine annually, Lonza said on Monday.

Venture financing for messenger ribonucleic acid (mRNA)-based innovator vaccines declined by 82% from $510m in 2023 to $90m ...

The amount of equity flowing into companies developing mRNA-based vaccines has significantly declined so far in 2025, ...

While mRNA changed the game in vaccines, leveraging the technology to develop treatments has been trickier to navigate.

The Armenian immigrant and Flagship Pioneering visionary has spent decades turning scientific impossibilities into ...

Moderna announced today that the first mRNA vaccines fully manufactured in Canada are being shipped to provinces and territories. This milestone advances Canada's domestic vaccine production capacity ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. recently terminated $500 million in federal funding for ...

Venture financing for mRNA-based innovator vaccines saw an 82% decline from $510 million in 2023 to $90 million in 2025 ...

Preliminary analysis showed the 2025-2026 formula of mNEXSPIKE generated greater than a 16-fold increase in LP.8.1-neutralizing antibodies across age groups Both of Moderna’s COVID-19 vaccines for the ...